Bioxytran, Inc.
BIXT
$0.04
$0.000.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.72% | -898.59% | 102.62% | -79.98% | -91.67% |
| Total Depreciation and Amortization | -30.95% | 68.00% | 31.58% | -34.48% | 93.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 2,391.20% |
| Total Other Non-Cash Items | 237.80% | 72.18% | -131.89% | 343.22% | -2,000.00% |
| Change in Net Operating Assets | -41.92% | 111.86% | -58.41% | 3.55% | 24.17% |
| Cash from Operations | -471.08% | 48.57% | 51.76% | -30.81% | -74.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -264.71% | 88.82% | -- | 100.00% | -12.04% |
| Cash from Investing | -264.71% | 88.82% | -- | 100.00% | -12.04% |
| Total Debt Issued | -49.51% | -56.45% | -43.18% | 50.68% | 4.74% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,076.12% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,255.23% | -42.39% | -43.18% | 50.68% | 4.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,245.61% | 1,050.00% | -50.00% | 97.29% | -239.15% |